Treatment options for latent tuberculosis infection

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Treatment options for latent tuberculosis infection

Published Date:

November 2011

Source:

TB elimination

Language:

English

[PDF-195.72 KB]

Details:

Corporate Authors:

National Center for HIV, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.

Description:

Treatment of latent tuberculosis (TB) infection (LTBI) is essential to controlling and eliminating TB in the United States, because it substantially reduces the risk that TB infection will progress to TB disease. Certain groups are at very high risk of developing TB disease once infected. Once the diagnosis of LTBI has been made, health care providers must choose the most appropriate and effective treatment regimen, and make every effort to ensure those persons complete the entire course of treatment for LTBI.

However, if exposed to and infected by a person with multidrug-resistant TB (MDR TB) or extensively drug-resistant TB (XDR TB), preventive treatment may not be an option.

Subject:

[+]

Document Type:

Pamphlet (or booklet)

Collection(s):

Stephen B. Thacker CDC Library collection

Main Document Checksum:

[+]

Supporting Files:

No Additional Files

No Related Documents.

You May Also Like:

Treatment options for latent tuberculosis infection

Corporate Authors:

National Center for HIV, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.

Published Date:

August 2016

Series:

TB elimination

Description:

Treatment of latent tuberculosis (TB) infection (LTBI) is essential to controlling and eliminatingTB in the United States, because it substantially reduces the risk that TB infection will progress to TB disease. The Centers for Disease Control and Pr...

File Type:

[PDF - 1.30 MB]
Tuberculosis : an overview

Corporate Authors:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.)

Published Date:

March 2014

Source:

CDC fact sheet

File Type:

[PDF - 113.40 KB]
Latent TB infection : CDC messages and resources : U.S. Preventive Services Task Force Recommendation on Latent Tuberculosis Infection

Corporate Authors:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.. U.S. Preventive Services Task Force..

Published Date:

Decmber 2016

Description:

The U.S. Preventive Services Task Force published a new recommendation to test for latent TB infection in populations at increased risk. The TB community has a unique opportunity to use the announcement of this recommendation to draw attention to lat...

File Type:

[PDF - 535.52 KB]
Use of Video Directly Observed Therapy for Treatment of Latent Tuberculosis Infection — Johnson County, Kansas, 2015

Personal Author:

Holzschuh, Elizabeth Lawlor; Province, Stacie; Johnson, Krystle; Walls, Caitlin; Shemwell, Cathy; Martin, Gary; Showalter, Amy; Dunlay, Jennifer; Conyers, Andrew; Griffin, Phil; Tausz, Nancy;

Published Date:

Apr 14 2017

Source:

MMWR Morb Mortal Wkly Rep. 66(14):387-389.

Description:

Tuberculosis (TB) is caused by the bacterium Mycobacterium tuberculosis and is spread from person to person through the air. TB can be spread in congregate settings, such as school environments, to varying degrees, based on factors including duration...

File Type:

[PDF - 83.04 KB]
Old and new approaches to diagnosing and treating latent tuberculosis in children in low-incidence countries

Personal Author:

Cruz, Andrea T.; Starke, Jeffrey R.; Lobato, Mark N.;

Published Date:

Feb 2014

Source:

Curr Opin Pediatr. 26(1):106-113.

Description:

Purpose of reviewThe primary purpose is to review guidance on the testing and treatment of latent tuberculosis infection (LTBI) in children. Most children and adults with LTBI have positive tuberculin skin test (TST) or interferon gamma release assay...

File Type:

[PDF - 123.82 KB]